Ravgen, Inc. v. Myriad Genetics, Inc. et al > Documents

Date Field	Doc. No.	Description (Pages)
Oct 6, 2023	220	NOTICE OF SERVICE of (1) Defendants' Objections and Responses to Plaintiff's First Set of Requests for Admission to Myriad (Nos. 1-50) and (2) Myriad Defendants' Objections and Responses to Plaintiff's Third Set of Common Interrogatories to Defendants (Nos. 19-20) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 10/06/2023) (4)
Sep 25, 2023	217	NOTICE OF SERVICE of (1) Defendants' Objections and Responses to Plaintiff's First Set of Requests for Admission to Myriad (Nos. 1-50); (2) Defendants' Objections and Responses to Plaintiff's Second Set of Interrogatories (No. 5); and (3) Myriad Defendants' Objections and Responses to Plaintiff's Third Set of Common Interrogatories to Defendants (Nos. 19-20) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 09/25/2023) (4)
Sep 25, 2023	218	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Defendants' Third Set of Common Interrogatories (Nos. 17-20) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023) (4)
Sep 25, 2023	219	NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants Myriad Genetics, Inc. and Myriad Women's Health, Inc.'s First Set of Requests for Admission (Nos. 1-37) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023) (2)
Sep 22, 2023	216	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/22/2023) (4)
Sep 19, 2023	215	MOTION for Pro Hac Vice Appearance of Attorney Gillian F. Moore and Kevin Goon - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 09/19/2023) (4)
Sep 15, 2023	214	NOTICE OF SERVICE of Myriad Defendants' Objections and Responses to Plaintiff's Second Set of Common Interrogatories to Defendants (Nos. 16-18) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 09/15/2023) (3)
Sep 13, 2023	212	NOTICE to Take Deposition of Marie Mount on 10/13/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/13/2023) (2)
Sep 13, 2023	213	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Amended Privilege Log filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/13/2023) (2)
Sep 8, 2023	210	ORAL ORDER: Defendants' Motion to Set an Early Inequitable Conduct Trial (C.A. No. 20-1646, D.I. 234; C.A. No. 20-1730, D.I. 157; C.A. No. 20-1734, D.I. 167) is DENIED. The Court is not persuaded under the circumstances that holding an inequitable conduct bench trial a year before the scheduled jury trial is the most efficient way to proceed with these cases. Ordered by Judge Jennifer L. Hall on 9/8/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 09/08/2023) (0)
Sep 8, 2023	211	STIPULATION Extending Case Schedule, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 09/08/2023) (4)
Sep 5, 2023	208	REDACTED VERSION of 206 Reply Brief, by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 9/5/2023 (nms). (Entered: 09/05/2023) (30)
Sep 5, 2023	209	NOTICE of Subpoena to Frank Garofalo - by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy) Modified on 9/5/2023 (nms). (Entered: 09/05/2023) (30)
Aug 29, 2023	207	NOTICE to Take Deposition of Ben Wheeler on 9/26/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/29/2023) (2)
Aug 28, 2023	206	[SEALED] REPLY BRIEF re 157 MOTION to Set an Inequitable Conduct Trial filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Certificate of Service)(Tigan, Jeremy) (Attachment 1 replaced on 8/29/2023) (lah). (Entered: 08/28/2023) (0)
Aug 25, 2023	205	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Privilege Log filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/25/2023) (2)
Aug 24, 2023	204	NOTICE to Take Deposition of Stephen Landt on 9/11/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/24/2023) (2)
Aug 23, 2023	199	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Requests for Admission to Myriad Genetics, Inc. and Myriad Women's Health, Inc. (Nos. 1-50) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023) (2)
Aug 23, 2023	200	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Third Set of Common Interrogatories to Defendants (Nos. 19-20) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023) (4)
Aug 23, 2023	201	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Requests for Admission (Authentication) to Myriad Genetics, Inc. and Myriad Women's Health, Inc. (Nos. 51318) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023) (3)
Aug 23, 2023	202	NOTICE OF SERVICE of Defendants' Third Set of Common Interrogatories to Plaintiff Ravgen, Inc. (Nos. 17-20) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/23/2023) (3)
Aug 23, 2023	203	NOTICE OF SERVICE of Defendants' First Set of Requests for Admission to Ravgen, Inc. filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 08/23/2023) (3)
Aug 22, 2023	198	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Interrogatories to Defendants Myriad Genetics, Inc. and Myriad Women's Health, Inc. (No. 5) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/22/2023) (2)
Aug 21, 2023	196	NOTICE OF SERVICE of (1) Defendants' Supplemental Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) and (2) Myriad Defendants' August 21, 2023 Supplemental Objections and Responses to Plaintiff's First Set of Common Interrogatories to Defendants (Nos. 1-15) - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 08/21/2023) (4)
Aug 21, 2023	197	NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Brian) (Entered: 08/21/2023) (0)
Aug 18, 2023	194	ORAL ORDER: Having reviewed the parties' letters (C.A. No. 20-1646, D.I. 262, 266; C.A. No. 20-1730, D.I. 189, 192; C.A. No. 20-1734, D.I. 185, 187), the Court is not convinced that it is appropriate to order case narrowing prior to the issuance of the claim construction order. Accordingly, IT IS HEREBY ORDERED that the discovery motion (C.A. No. 20-1646, D.I. 241; C.A. No. 20-1730, D.I. 171; C.A. No. 20-1734, D.I. 170) is DENIED without prejudice to re-raise after issuance of the claim construction order. The parties must meet and confer prior to a subsequent discovery motion raising this issue. The parties are encouraged to continue working towards narrowing the case in the interim. Accordingly, the teleconference scheduled for August 18, 2023 at 3:00 pm is CANCELLED. Ordered by Judge Jennifer L. Hall on 8/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/18/2023) (0)
Aug 18, 2023	195	NOTICE requesting Clerk to remove Anne S. Toker as co-counsel.. (Tigan, Jeremy) (Entered: 08/18/2023) (2)
Aug 17, 2023	193	STIPULATION and Proposed Order to Extend Time to file a Reply Brief in Support of Motion to Set an Inequitable Conduct Trial to August 28, 2023 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 8/18/2023 (nms). (Entered: 08/17/2023) (2)
Aug 16, 2023	190	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Common Interrogatories to Defendants (Nos. 16-18) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/16/2023) (4)
Aug 16, 2023	191	NOTICE to Take Deposition of Anupama Srinivasan on 9/5/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/16/2023) (2)
Aug 16, 2023	192	Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding response to Defendants' August 14, 2023, letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Michael) Modified on 8/16/2023 (nms). (Entered: 08/16/2023) (0)
Aug 14, 2023	186	ANSWERING BRIEF in Opposition re 157 MOTION to Set an Inequitable Conduct Trial filed by Ravgen, Inc..Reply Brief due date per Local Rules is 8/21/2023. (Farnan, Brian) (Entered: 08/14/2023) (18)
Aug 14, 2023	187	DECLARATION of Julianne Thomsen re 186 Answering Brief in Opposition by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6) (Farnan, Brian) Modified on 8/14/2023 (ceg). Modified on 8/15/2023 (nms). (Entered: 08/14/2023) (0)
Aug 14, 2023	188	RESPONSE to 158 Objections, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) Modified on 8/15/2023 (nms). (Entered: 08/14/2023) (11)
Aug 14, 2023	189	Letter to The Honorable Jennifer L. Hall, from Daniel M. Silver, regarding discovery dispute on claim narrowing. (Attachments: # 1 Proposed Order, # 2 Exhibits 1-5)(Silver, Daniel) Modified on 8/15/2023 (nms). (Entered: 08/14/2023) (0)
Aug 11, 2023	185	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Defendants' Second Set of Common Interrogatories (Nos. 15-16) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/11/2023) (4)
Aug 10, 2023	182	REDACTED VERSION of 170 Letter, by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Tigan, Jeremy) (Entered: 08/10/2023) (0)
Aug 10, 2023	183	DECLARATION of Bradley Roush in support of 182 Redacted Document, by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy) Modified on 8/10/2023 (nms). (Entered: 08/10/2023) (4)
Aug 10, 2023	184	NOTICE of Subpoena by Ravgen, Inc. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/10/2023) (0)
Aug 9, 2023	181	NOTICE of Subpoena to Deborah S. Kipp by Ravgen, Inc. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/09/2023) (0)
Aug 8, 2023	180	MOTION for Pro Hac Vice Appearance of Attorney Jennifer Przybylski - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian) (Entered: 08/08/2023) (3)
Aug 7, 2023	178	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendants' Third Set of Requests for Production of Documents and Things (Nos. 87-99) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/07/2023) (2)
Aug 7, 2023	179	RESPONSE to 143 Objections, by Ravgen, Inc.. (Farnan, Brian) Modified on 8/8/2023 (nms). (Entered: 08/07/2023) (14)
Aug 4, 2023	171	MOTION for Teleconference to Resolve Discovery Dispute - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 08/04/2023) (3)
Aug 4, 2023	172	NOTICE of Subpoena to Alicia Hager by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/04/2023) (0)
Aug 4, 2023	173	ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Disputes (C.A. No. 20-1646, D.I. 241; C.A. No. 20-1730, D.I. 171; C.A. No. 20-1734, D.I. 170). A discovery dispute teleconference is scheduled for August 18, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 14, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 16, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. The letter shall address all outstanding discovery disputes. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 8/4/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/04/2023) (0)
Aug 4, 2023	174	NOTICE of Subpoena to Marian Damewood by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/04/2023) (0)
Aug 4, 2023	175	NOTICE of Subpoena to Subhendra Mattagajasingh by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/04/2023) (0)
Aug 4, 2023	176	ORAL ORDER: Having reviewed the parties' letters (D.I. 160 , 170 ), it appearing that Defendant Myriad Genetics, Inc. is in the process of producing the requested documents, IT IS HEREBY ORDERED that Ravgen, Inc.'s Discovery Motion (D.I. 151 ) is DENIED without prejudice to re-raise at the August 18 teleconference if there are any remaining disputes. Any such disputes should be addressed in the letters filed in conjunction with the August 18 teleconference. The Discovery Dispute Teleconference scheduled for August 7, 2023 is CANCELLED. Ordered by Judge Jennifer L. Hall on 8/4/2023. (ceg) (Entered: 08/04/2023) (0)
Aug 4, 2023	177	NOTICE of Subpoena to Wei-Chun Au by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/04/2023) (0)
Aug 3, 2023	164	NOTICE to Take Deposition of Jeremiah Bennett on 8/25/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/03/2023) (2)
Aug 3, 2023	165	NOTICE to Take Deposition of Kevin Haas on 8/28/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/03/2023) (2)
Aug 3, 2023	166	NOTICE to Take Deposition of Dale Muzzey on 8/31/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/03/2023) (2)
Aug 3, 2023	167	NOTICE to Take Deposition of Helen Wan on 8/29/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/03/2023) (2)
Aug 3, 2023	168	NOTICE to Take Deposition of John Varney on September 6, 2023 filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 08/03/2023) (3)
Aug 3, 2023	169	NOTICE to Take Deposition of Xin Guo on September 19, 2023 filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 08/03/2023) (3)
Aug 3, 2023	170	[SEALED] Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding discovery dispute. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Tigan, Jeremy) Modified on 8/3/2023 (nms). (Entered: 08/03/2023) (0)
Aug 2, 2023	161	NOTICE of Subpoena to Husch Blackwell LLP by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/02/2023) (0)
Aug 2, 2023	162	NOTICE of Subpoena to Michael J. Cronin by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/02/2023) (0)
Aug 2, 2023	163	NOTICE OF SERVICE of Plaintiff Ravgen Inc.'s Objections and Responses to Defendants Myriad Genetics, Inc. and Myriad Women's Health, Inc.'s Notice of Deposition to Ravgen, Inc. filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/02/2023) (2)
Aug 1, 2023	159	MOTION for Pro Hac Vice Appearance of Attorney Nicholas O. Kennedy - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) (Entered: 08/01/2023) (4)
Aug 1, 2023	160	Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding discovery dispute. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9) (Farnan, Brian) Modified on 8/1/2023 (ceg). (Entered: 08/01/2023) (0)
Jul 31, 2023	156	ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Disputes (D.I. 151 ). A discovery dispute teleconference is scheduled for August 7, 2023 at 4:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 1, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 3, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 7/31/2023. (ceg) (Entered: 07/31/2023) (0)
Jul 31, 2023	157	MOTION to Set an Inequitable Conduct Trial - filed by Biora Therapeutics, Inc.. (Attachments: # 17.1.1 Certification, # 2 Proposed Order, # 3 Exhibits 1-31)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) Modified on 8/1/2023 (nms). (Entered: 07/31/2023) (0)
Jul 31, 2023	158	OBJECTION to 139 Report and Recommendations, by Ravgen, Inc.. (Attachments: # 1 Certification)(Farnan, Brian) Modified on 8/1/2023 (nms). (Entered: 07/31/2023) (0)
Jul 28, 2023	155	NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Interrogatories to Defendants (Nos. 1-4) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 07/28/2023) (3)
Jul 27, 2023	154	ANSWER to 144 Amended Answer to Complaint, Counterclaim by Ravgen, Inc..(Farnan, Brian) (Entered: 07/27/2023) (10)
Jul 26, 2023	153	NOTICE requesting Clerk to remove Peter J. Armenio, Colleen Tracy James, and the law firm of White & Case LLP as co-counsel.. (Tigan, Jeremy) (Entered: 07/26/2023) (3)
Jul 24, 2023	151	MOTION for Teleconference to Resolve Disputes - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian) (Entered: 07/24/2023) (3)
Jul 24, 2023	152	MOTION for Pro Hac Vice Appearance of Attorney Thomas James - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) (Entered: 07/24/2023) (4)
Jul 19, 2023	147	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/19/2023) (3)
Jul 19, 2023	148	STIPULATION Extending the deadlines for: (i) Plaintiff to file its objections to the Report and Recommendation and (ii) Plaintiff to respond to Defendants' Objection to (i) 7/31/2023 and (ii) 8/7/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/19/2023) (3)
Jul 19, 2023	149	JOINT Interim Status Report, by Ravgen, Inc.. (Farnan, Brian) Modified on 7/19/2023 (nms). (Entered: 07/19/2023) (4)
Jul 19, 2023	150	NOTICE OF SERVICE of Myriad Defendants' Responses and Objections to Ravgen's "Second" Notice of Deposition to Myriad (Topic Nos. 19-90) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 07/19/2023) (3)
Jul 18, 2023	146	NOTICE OF SERVICE of (1) Defendants' Notice of Deposition of Ravinder Dhallan and (2) Defendants' Notice of Deposition to Ravgen, Inc. filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 07/18/2023) (3)
Jul 14, 2023	145	NOTICE OF SERVICE of Myriad Defendants' Objections and Responses to Plaintiff's First Set of Common Interrogatories to Defendants (Nos. 1-15) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 07/14/2023) (3)
Jul 13, 2023	144	AMENDED Answer to 1 Complaint, and COUNTERCLAIMS against Ravgen, Inc., by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Attachments: # 1 Exhibits A-L)(Tigan, Jeremy) Modified on 7/13/2023 (nms). (Entered: 07/13/2023) (0)
Jul 12, 2023	140	STIPULATION Extending Deadline to submit the Joint Interim Status Report to 7/19/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/12/2023) (2)
Jul 12, 2023	141	REDACTED VERSION of 136 Notice to Take Deposition by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/12/2023) (19)
Jul 12, 2023	142	NOTICE OF SERVICE of Defendants' Second Set of Common Interrogatories to Plaintiff Ravgen, Inc. (Nos. 15-16) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 07/12/2023) (3)
Jul 12, 2023	143	OBJECTIONS to 139 Report and Recommendations, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. . (Attachments: # 1 Certification, # 2 Exhibits A-B)(Haynes, Christine) Modified on 7/12/2023 (nms). (Entered: 07/12/2023) (0)
Jul 10, 2023	139	REPORT AND RECOMMENDATION re Claim Construction Disputes. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/24/2023. Signed by Judge Jennifer L. Hall on 7/10/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/10/2023) (16)
Jul 6, 2023	137	CERTIFICATE of Service re 136 Sealed Notice to Take Deposition, by Ravgen, Inc.. (Farnan, Brian) Modified on 7/6/2023 (nms). (Entered: 07/06/2023) (2)
Jul 6, 2023	138	NOTICE OF SERVICE of Defendants' Third Set of Requests for the Production of Documents and Things for Plaintiff Ravgen, Inc. (Nos. 87-99) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 07/06/2023) (3)
Jul 5, 2023	136	[SEALED] NOTICE to Take Deposition of Defendants on August 4, 2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/05/2023) (0)
Jun 28, 2023	135	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Interrogatories to Defendants Myriad Genetics, Inc. and Myriad Womens Health, Inc. (Nos. 1-4) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/28/2023) (2)
Jun 22, 2023	134	MOTION for Pro Hac Vice Appearance of Attorney John G. Flaim and Heiko E. Burow - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) (Entered: 06/22/2023) (5)
Jun 21, 2023	132	Letter to The Honorable Richard G. Andrews, from Brian E. Farnan, regarding proposed claim construction order. (Attachments: # 1 Exhibit 1)(Farnan, Brian) Modified on 6/21/2023 (nms). (Entered: 06/21/2023) (0)
Jun 21, 2023	133	CLAIM CONSTRUCTION ORDER CONSTRUING AGREED TERMS (see Order for further details). Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(nms) (Entered: 06/21/2023) (2)
Jun 16, 2023	130	NOTICE OF SERVICE of Myriad Defendants' Responses and Objections to Ravgen's "First" Notice of Deposition to Myriad filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 06/16/2023) (3)
Jun 16, 2023	131	MOTION for Pro Hac Vice Appearance of Attorney Liane M. Peterson, Bradley Roush and Tiffany K. Sung - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) (Entered: 06/16/2023) (6)
Jun 14, 2023	129	NOTICE OF SERVICE of Defendants' Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 06/14/2023) (3)
Jun 5, 2023	128	NOTICE OF SERVICE of Plaintiff Ravgen's First Responses To Defendants' First Set Of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Michael) (Entered: 06/05/2023) (4)
Jun 2, 2023	126	NOTICE to Take Deposition of Myriad Inc. and Myriad Womens Health, Inc. on 6/22/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/02/2023) (9)
Jun 2, 2023	127	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-15) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/02/2023) (4)
May 31, 2023	125	ORAL ORDER Setting Teleconference: A teleconference is scheduled for June 1, 2023 at 4:00 PM before Judge Jennifer L. Hall, at which time the Court anticipates issuing its Report and Recommendation on the pending claim construction disputes. Counsel shall send dial-in information directly to the Court using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. Ordered by Judge Jennifer L. Hall on 5/31/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/31/2023) (0)
May 30, 2023	124	ORDER granting Joint Motion for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices (C.A. 20-1646, D.I. 175; C.A. No. 20-1730, D.I. 122; C.A. No. 20-1734, D.I. 133). Signed by Judge Jennifer L. Hall on 5/30/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Main Document 124 replaced on 5/30/2023) (ceg). (Entered: 05/30/2023) (2)
May 28, 2023	123	Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding agreed-upon construction of "Mutation" in advance of the Markman hearing. (Tigan, Jeremy) Modified on 5/30/2023 (nms). (Entered: 05/28/2023) (2)
May 26, 2023	122	MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 05/26/2023) (0)
May 24, 2023	121	Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding deposition limitations. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) Modified on 5/25/2023 (nms). (Entered: 05/24/2023) (0)
May 19, 2023	120	STIPULATION TO EXTEND TIME for the Joint Status Report on Deposition Limitations to 5/24/2023 - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/19/2023) (2)
May 18, 2023	119	ORAL ORDER: The Markman hearing scheduled for May 31, 2023 at 10:00 AM before Judge Hall will be conducted in-person in courtroom TBD. Each side shall be allocated 90 minutes for its presentation (i.e., the total allocation of time for the hearing will be 3 hours). Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Ordered by Judge Jennifer L. Hall on 5/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/18/2023) (0)
May 16, 2023	118	NOTICE of Subsequent Authority Regarding Claim Construction by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Farnan, Brian) (Entered: 05/16/2023) (0)
May 5, 2023	116	NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) (Entered: 05/05/2023) (0)
May 5, 2023	117	NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 05/05/2023) (2)
Apr 28, 2023	115	NOTICE OF SERVICE of Ravgen's Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/28/2023) (2)
Apr 24, 2023	113	NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendants' Second Set of Requests for the Production of Documents and Things (Nos. 62-86) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/24/2023) (2)
Apr 24, 2023	114	NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's Second Set of Requests for the Production of Documents and Things filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 04/24/2023) (3)
Apr 21, 2023	112	MOTION for Pro Hac Vice Appearance of Attorney Frederick J. Ding, Julianne M. Thomsen, and William B. Nichols - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 04/21/2023) (5)
Apr 17, 2023	111	REDACTED VERSION of 108 Appendix, Volume 4 of 4, by Ravgen, Inc.. (Attachments: # 1 Exhibit D27, # 2 Exhibit D28, # 3 Exhibit D29, # 4 Exhibit D30, # 5 Exhibit D31, # 6 Exhibit D32, # 7 Exhibit D33, # 8 Exhibit D34, # 9 Exhibit D35, # 10 Exhibit D36, # 11 Exhibit D37, # 12 Exhibit D38, # 13 Exhibit D39, # 14 Exhibit D40, # 15 Exhibit D41, # 16 Exhibit D42, # 17 Exhibit D43, # 18 Exhibit D44, # 19 Exhibit D45, # 20 Exhibit D46, # 21 Exhibit D47, # 22 Exhibit D48, # 23 Exhibit D49, # 24 Exhibit D50, # 25 Exhibit D51, # 26 Exhibit D52, # 27 Exhibit D53, # 28 Exhibit D54, # 29 Exhibit D55, # 30 Exhibit D56, # 31 Exhibit D57, # 32 Exhibit D58, # 33 Exhibit D59, # 34 Exhibit D60, # 35 Certificate of Service)(Farnan, Michael) Modified on 4/17/2023 (nms). (Entered: 04/17/2023) (0)
Apr 12, 2023	110	NOTICE of Lodging Defendants' Technology Tutorial with the Court by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Tigan, Jeremy) (Entered: 04/12/2023) (2)
Apr 10, 2023	103	NOTICE of filing the following Non-Paper material(s) in multi media format: Plaintiff's Technology Tutorial. Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Brian E. Farnan on behalf of Ravgen, Inc. (Farnan, Brian) (Entered: 04/10/2023) (3)
Apr 10, 2023	104	JOINT Claim Construction Brief, filed by Ravgen, Inc.. (Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (30)
Apr 10, 2023	105	APPENDIX, Volume 1 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0)
Apr 10, 2023	106	APPENDIX, Volume 2 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit P30, # 2 Exhibit P31, # 3 Exhibit P32, # 4 Exhibit P33, # 5 Exhibit P34, # 6 Exhibit P35, # 7 Exhibit P36, # 8 Exhibit P37, # 9 Exhibit P38, # 10 Exhibit P39, # 11 Exhibit P40, # 12 Exhibit P41, # 13 Exhibit P42, # 14 Exhibit P43, # 15 Exhibit P44, # 16 Exhibit P45, # 17 Exhibit P46, # 18 Exhibit P47, # 19 Exhibit P48, # 20 Exhibit P49, # 21 Exhibit P50, # 22 Exhibit P51, # 23 Exhibit P52, # 24 Exhibit P53, # 25 Exhibit P54, # 26 Exhibit P55, # 27 Exhibit P56, # 28 Exhibit P57, # 29 Exhibit P58)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0)
Apr 10, 2023	107	APPENDIX, Volume 3 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit D1, # 2 Exhibit D2, # 3 Exhibit D3, # 4 Exhibit D4, # 5 Exhibit D5, # 6 Exhibit D6, # 7 Exhibit D7, # 8 Exhibit D8, # 9 Exhibit D9, # 10 Exhibit D10, # 11 Exhibit D11, # 12 Exhibit D12, # 13 Exhibit D13, # 14 Exhibit D14, # 15 Exhibit D15, # 16 Exhibit D16, # 17 Exhibit D17, # 18 Exhibit D18, # 19 Exhibit D19, # 20 Exhibit D20, # 21 Exhibit D21, # 22 Exhibit D22, # 23 Exhibit D23, # 24 Exhibit D24, # 25 Exhibit D25, # 26 Exhibit D26)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0)
Apr 10, 2023	108	[SEALED] APPENDIX, Volume 4 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit D27, # 2 Exhibit D28, # 3 Exhibit D29, # 4 Exhibit D30, # 5 Exhibit D31, # 6 Exhibit D32, # 7 Exhibit D33, # 8 Exhibit D34, # 9 Exhibit D35, # 10 Exhibit D36, # 11 Exhibit D37, # 12 Exhibit D38, # 13 Exhibit D39, # 14 Exhibit D40, # 15 Exhibit D41, # 16 Exhibit D42, # 17 Exhibit D43, # 18 Exhibit D44, # 19 Exhibit D45, # 20 Exhibit D46, # 21 Exhibit D47, # 22 Exhibit D48, # 23 Exhibit D49, # 24 Exhibit D50, # 25 Exhibit D51, # 26 Exhibit D52, # 27 Exhibit D53, # 28 Exhibit D54, # 29 Exhibit D55, # 30 Exhibit D56, # 31 Exhibit D57, # 32 Exhibit D58, # 33 Exhibit D59, # 34 Exhibit D60, # 35 Certificate of Service)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0)
Apr 10, 2023	109	Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding Markman hearing. (Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (1)
Apr 4, 2023	101	REDACTED VERSION of 95 Letter by Ravgen, Inc.. (Farnan, Michael) (Entered: 04/04/2023) (7)
Apr 4, 2023	102	NOTICE OF SERVICE of 1) Defendants' Sur-Reply Construction Brief; 2) Declaration of R. Noyes in Support of Defendants' Sur-Reply Claim Construction Brief; and 3) Declaration of Michael L. Metzker in Support of Defendants' Sur-Reply Claim Construction Brief filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 04/04/2023) (2)
Mar 30, 2023	100	ORAL ORDER: The redacted filing D.I. 98 is REJECTED because parts of it are redacted in its entirety. Absent a compelling reason, supported by a statement under oath by a party, redactions in their entirety are impermissible; redactions must be done so as to redact the least possible amount of the materials submitted. Failure to make a good faith attempt at such redactions may result in sanctions, the most common of which would be simply unsealing the entire filing. Redacting in its entirety a document that contains publicly available materials is prima facie evidence of bad faith. Revised redacted filings are DUE within five business days. Ordered by Judge Richard G. Andrews on 3/30/2023. (nms) (Entered: 03/30/2023) (0)
Mar 29, 2023	98	REDACTED VERSION of 95 Letter by Ravgen, Inc.. (Farnan, Michael) (Entered: 03/29/2023) (7)
Mar 29, 2023	99	ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the March 29, 2023 discovery dispute teleconference shall serve as the Order of the Court. Ordered by Judge Jennifer L. Hall on 3/29/2023. Associated Cases: 1:20-cv-01734-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg) (Entered: 03/29/2023) (0)
Mar 28, 2023	97	AMENDED SCHEDULING ORDER: Claim Construction Surreply Brief due by 4/3/2023. Joint Claim Construction Brief and Technology Tutorials due by 4/10/2023. A Markman Hearing is set for 5/31/2023 at 10:00 AM before Judge Jennifer L. Hall. Interim Status Report due by 7/15/2023. Joinder of Parties due by 7/26/2023. Amended Pleadings due by 7/26/2023. Fact Discovery completed by 9/22/2023. Expert Discovery due by 2/16/2024. Case Dispositive Motions due by 4/4/2024. Answering Brief due 5/2/2024. Reply Brief due 5/16/2024. A Motion Hearing is set for 6/13/2024 at 01:00 PM before Judge Jennifer L. Hall. A Trial Sequencing Conference is set for 4/22/2024 at 01:00 PM before Judge Jennifer L. Hall. Proposed Pretrial Order due by 10/14/2024. A Pretrial Conference is set for 10/18/2024 at 09:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 5-day Jury Trial is set for 10/28/2024 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for details). Signed by Judge Jennifer L. Hall on 3/28/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/28/2023) (15)
Mar 24, 2023	96	PROPOSED Amended Scheduling Order, by Ravgen, Inc.. (Attachments: # 1 Letter)(Farnan, Michael) Modified on 3/24/2023 (nms). (Entered: 03/24/2023) (0)
Mar 23, 2023	95	[SEALED] Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding response to Defendants' March 17, 2023 Letter (D.I. 93 ). (Attachments: # 1 Exhibit A) (Farnan, Brian) Modified on 3/23/2023 (nms). (Entered: 03/23/2023) (0)
Mar 17, 2023	91	ORAL ORDER: Myriad's request to join the March 29, 2023 teleconference (D.I. 90 ) is granted. Myriad's request to file a one-page letter brief is granted; Ravgen may file a one-page response. Ordered by Judge Jennifer L. Hall on 3/17/2023. (ceg) (Entered: 03/17/2023) (0)
Mar 17, 2023	92	NOTICE OF SERVICE of Plaintiff's Second Set of Requests for the Production of Documents and Things (Nos. 71-74) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 03/17/2023) (2)
Mar 17, 2023	93	Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding Motion for Leave to Amend its Answer and Affirmative Defenses to Add License, Release, and Inequitable Conduct Defenses and Counterclaims. (Attachments: # 1 Exhibit 1, # 2 Exhibits A-L, # 3 Exhibit 2, # 4 Proposed Order)(Tigan, Jeremy) Modified on 3/17/2023 (nms). (Entered: 03/17/2023) (0)
Mar 17, 2023	94	NOTICE OF SERVICE of Defendants' Second Set of Requests for the Production of Documents and Things for Plaintiff Ravgen, Inc. (Nos. 62-86) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 03/17/2023) (3)
Mar 16, 2023	90	Joint Motion to Join March 29, 2023 Teleconference to Resolve Disputes Regarding Motion to Amend Answer - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (3)
Mar 8, 2023	89	MOTION for Pro Hac Vice Appearance of Attorney Benjamin N. Luehrs and Kyle G. Petrie - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 03/08/2023) (4)
Mar 7, 2023	88	ORAL ORDER Setting Telephonic Scheduling Conference: A Scheduling Conference is scheduled for March 10, 2023 at 10:00 AM before Judge Jennifer L. Hall. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. Ordered by Judge Jennifer L. Hall on 3/7/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/07/2023) (0)
Mar 6, 2023	87	PROPOSED Amended Scheduling Order by Ravgen, Inc. (Attachments: # 1 Letter to The Honorable Jennifer L. Hall)(Farnan, Michael) Modified docket text on 3/6/2023 (ceg). (Entered: 03/06/2023) (0)
Mar 1, 2023	86	MOTION for Pro Hac Vice Appearance of Attorney Colleen Tracy James - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) (Entered: 03/01/2023) (4)
Feb 27, 2023	85	STIPULATION Extending Deadline to Submit a Scheduling Order to 3/6/2023 - filed by Ravgen, Inc.. (Farnan, Michael) Modified on 2/28/2023 (nms). (Entered: 02/27/2023) (3)
Feb 13, 2023	84	ORAL ORDER: The request to lift the stay (D.I. 79 ) is GRANTED. The parties shall meet and confer and submit a proposed scheduling order on or before February 27, 2023. ORDERED by Judge Jennifer L. Hall on 2/13/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 02/13/2023) (0)
Feb 6, 2023	83	JOINT Status Report, by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Brian) Modified on 2/7/2023 (nms). (Entered: 02/06/2023) (0)
Feb 1, 2023	82	STIPULATION Extending Deadline to Submit Status Report to February 6, 2023 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Cottrell, Frederick) Modified on 2/2/2023 (nms). (Entered: 02/01/2023) (3)
Jan 9, 2023	81	ORAL ORDER: The parties shall file an updated status report on February 2, 2023. ORDERED by Judge Jennifer L. Hall on 1/9/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 01/09/2023) (0)
Jan 4, 2023	80	Joint Status Report, by Ravgen, Inc.. (Farnan, Brian) Modified on 1/4/2023 (nms). (Entered: 01/04/2023) (10)
Dec 21, 2022	79	STIPULATION to Extend Time to submit status report - filed by Ravgen, Inc.. (Farnan, Michael) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (3)
Nov 11, 2022	78	Status Report (Main Document) (12) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms).
Nov 11, 2022	78	Status Report (Exhibit A) (30) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms).
Nov 11, 2022	78	Status Report (Exhibit B) (30) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms).
Nov 11, 2022	78	Status Report (Exhibit C) (30) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms).
Nov 9, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation and Order to Extend Time for the parties to file a joint status report to November 11, 2022. (73 in 1:20-cv-01644-RGA-JLH, 115 in 1:20-cv-01646-RGA-JLH, 77 in 1:20-cv-01730-RGA-JLH, 67 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/9/2022. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Nov 8, 2022	77	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a joint status report to November 11, 2022 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc., Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc., Illumina, Inc., Verinata Health, Inc., Progenity, Inc.. (Tigan, Jeremy)
Apr 4, 2022	N/A	Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. � 652(b). (Taylor, Daniel)
Mar 14, 2022	76	SO ORDERED (3) Docket Text: SO ORDERED, [75] Stipulation and Order Regarding Estoppel as to Myriad Genetics, Inc., Myriad Women's Health, Inc. Signed by Judge Jennifer L. Hall on 3/14/2022. (ceg)
Mar 8, 2022	75	Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Estoppel by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy)
Mar 1, 2022	N/A	Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 3/1/2022 via video conference re Defendant Myriad's Motion to Stay (C.A. No. 20-1730, D.I. 52), and the Notices of Joinder filed by Defendants Ilumina (C.A. No. 20-1644, D.I. 59), Roche, FMI (C.A. No. 1646, D.I. 100), and Progenity (C.A. No. 20-1734, D.I. 54) (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Mar 1, 2022	N/A	Order on Motion to Stay (0) Docket Text: ORAL ORDER: For the reasons announced from the bench at the March 1, 2022 hearing, Defendants' Motions to Stay (C.A. No. 20-1730, D.I. 52; C.A. No. 20-1644, D.I. 59; C.A. No. 20-1646, D.I. 100; C.A. No. 20-1734, D.I. 54) are GRANTED subject to non-petitioner Defendants filing within 7 days a stipulation of estoppel consistent with the hearing today. Within 7 days of any final written decision from the PTAB in any related IPR, the parties shall submit a joint status report to the Court indicating whether they wish to extend the stay. If the parties are not in agreement, the joint status report should include at least an updated chart of challenged claims and IPR decisions similar to the chart in the previous joint letter (C.A. No. 20-1730, D.I. 72) and should set forth the parties' positions. ORDERED by Judge Jennifer L. Hall on 3/1/2022. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Feb 28, 2022	72	Letter (6) Docket Text: Letter to The Honorable Jennifer L. Hall, from Frederick L. Cottrell, III, regarding response to the Court's Oral Order of February 24, 2022. (Cottrell, Frederick) Modified on 2/28/2022 (ceg). Modified on 2/28/2022 (nms).
Feb 28, 2022	73	Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Brian G. Van Ness, Ph.D. on March 1, 2022 filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Feb 24, 2022	N/A	Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER Setting Hearing on Motions: Having reviewed Defendant Myriad's Motion to Stay (C.A. No. 20-1730, D.I. 52), and the briefing filed in support thereof and in opposition thereto, and having reviewed the Notices of Joinder filed by Defendants Ilumina (C.A. No. 20-1644, D.I. 59), Roche, FMI (C.A. No. 1646, D.I. 100), and Progenity (C.A. No. 20-1734, D.I. 54) it is HEREBY ORDERED that a brief hearing on the motions is scheduled for March 1, 2022 at 9:00 AM via video conference before Judge Jennifer L. Hall. On or before noon on February 28, 2022, the parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be speaking on behalf of each party. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Also, on or before noon on February 28, 2022, the parties shall meet and confer and file a joint letter setting forth the following: (A) a chart that will enable the Court to easily identify which claims are asserted against each party in these litigations, which claims are at issue in the reexamination(s), which claims are at issue in the instituted IPRs and the IPRs for which an institution decision is still pending, and which claims are at issue in this litigation but are not otherwise being challenged at the PTO; and (B) whether the parties can agree on the scope of estoppel that should apply to the non-petitioner defendants if a stay is granted and, if not, the parties' respective positions on any estoppel that should be required as a condition of any stay entered by the Court. ORDERED by Judge Jennifer L. Hall on 2/24/2022. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Feb 24, 2022	69	Statement (9) Docket Text: OPPOSITION to [66] Joinder, by Ravgen, Inc.. (Farnan, Brian) Modified on 2/24/2022 (nms).
Feb 24, 2022	71	Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [70] Declaration, by Ravgen, Inc.. (Attachments: # (1) Exhibits 1-10, # (2) Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms).
Feb 24, 2022	71	Redacted Document (Exhibits 1-10) (30) Docket Text: REDACTED VERSION of [70] Declaration, by Ravgen, Inc.. (Attachments: # (1) Exhibits 1-10, # (2) Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms).
Feb 24, 2022	71	Redacted Document (Certificate of Service) (2) Docket Text: REDACTED VERSION of [70] Declaration, by Ravgen, Inc.. (Attachments: # (1) Exhibits 1-10, # (2) Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms).
Feb 14, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, [67] Stipulation to Extend the deadline for the substantial completion of document production to March 15, 2022. ORDERED by Judge Jennifer L. Hall on 2/14/2022. (ceg)
Feb 14, 2022	67	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the deadline for the substantial completion of document production to March 15, 2022 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Simonetti, Sarah)
Feb 11, 2022	66	Joinder (Main Document) (5) Docket Text: JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) 7.1.1 Certification, # (2) Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms).
Feb 11, 2022	66	Joinder (7.1.1 Certification) (1) Docket Text: JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) 7.1.1 Certification, # (2) Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms).
Feb 11, 2022	66	Joinder (Text of Proposed Order) (2) Docket Text: JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) 7.1.1 Certification, # (2) Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms).
Jan 28, 2022	65	Notice (Other) (Main Document) (3) Docket Text: NOTICE of Additional IPR Institution Decisions by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Simonetti, Sarah)
Jan 28, 2022	65	Notice (Other) (Exhibit A) (30) Docket Text: NOTICE of Additional IPR Institution Decisions by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Simonetti, Sarah)
Jan 28, 2022	65	Notice (Other) (Exhibit B) (30) Docket Text: NOTICE of Additional IPR Institution Decisions by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Simonetti, Sarah)
Jan 21, 2022	64	Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' Answering Claim Construction Brief, (2) Declaration of Omar A. Khan in Support of Defendants' Answering Claim Construction Brief, and (3) Declaration of Dr. Michael L. Metzker in Support of Answering Claim Construction Brief filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Delcollo, Renee)
Jan 13, 2022	63	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Allyson E. Parks as co-counsel. Reason for request: No longer with firm. (Tigan, Jeremy)
Dec 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation and Order to Extend Time (96 in 1:20-cv-01646-RGA-JLH, 52 in 1:20-cv-01734-RGA-JLH, 56 in 1:20-cv-01644-RGA-JLH, 59 in 1:20-cv-01730-RGA-JLH). *Reset Deadlines for Claim Construction Briefing: Claim Construction Answering Brief due by 1/21/2022; Claim Construction Reply Brief due by 2/11/2022; Claim Construction Surreply Brief due by 3/4/2022; Joint Claim Construction Brief; Tutorial on the technology due by 3/9/2022. ORDERED by Judge Jennifer L. Hall on 12/29/2021. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Dec 23, 2021	61	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendants' First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-61) filed by Ravgen, Inc..(Farnan, Brian)
Dec 23, 2021	62	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Dec 22, 2021	60	Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Myriad Genetics, Inc., Myriad Women's Health, Inc. re [52] MOTION to Stay Pending Instituted Inter Partes Reviews. (Tigan, Jeremy)
Dec 21, 2021	59	Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified on 12/23/2021 (nms).
Dec 20, 2021	58	Reply Brief (Main Document) (15) Docket Text: REPLY BRIEF re [52] MOTION to Stay Pending Instituted Inter Partes Reviews filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Attachments: # (1) Exhibit A-F)(Tigan, Jeremy)
Dec 20, 2021	58	Reply Brief (Exhibit A-F) (30) Docket Text: REPLY BRIEF re [52] MOTION to Stay Pending Instituted Inter Partes Reviews filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Attachments: # (1) Exhibit A-F)(Tigan, Jeremy)
Dec 13, 2021	56	Answering Brief in Opposition (19) Docket Text: ANSWERING BRIEF in Opposition re [52] MOTION to Stay Pending Instituted Inter Partes Reviews filed by Ravgen, Inc..Reply Brief due date per Local Rules is 12/20/2021. (Farnan, Brian)
Dec 13, 2021	57	Declaration (Main Document) (2) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 13, 2021	57	Declaration (Exhibit 1) (5) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 13, 2021	57	Declaration (Exhibit 2) (5) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 13, 2021	57	Declaration (Exhibit 3) (3) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 13, 2021	57	Declaration (Exhibit 4) (3) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 13, 2021	57	Declaration (Exhibit 5) (30) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 13, 2021	57	Declaration (Exhibit 6) (29) Docket Text: DECLARATION of Brian D. Matty re [56] Answering Brief in Opposition, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Farnan, Brian) Modified on 12/14/2021 (nms).
Dec 10, 2021	55	SO ORDERED (30) Docket Text: SO ORDERED, re Stipulated Protective Order. (88 in 1:20-cv-01646-RGA-JLH, 49 in 1:20-cv-01734-RGA-JLH, 50 in 1:20-cv-01644-RGA-JLH, 54 in 1:20-cv-01730-RGA-JLH). Signed by Judge Jennifer L. Hall on 12/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Dec 8, 2021	54	Proposed Order (30) Docket Text: PROPOSED Stipulated Protective Order by Ravgen, Inc. (Farnan, Brian) Modified on 12/8/2021 (ceg).
Nov 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to submit the proposed Protective Order to 12/8/2021. (87 in 1:20-cv-01646-RGA-JLH, 49 in 1:20-cv-01644-RGA-JLH, 48 in 1:20-cv-01734-RGA-JLH, 51 in 1:20-cv-01730-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/29/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Nov 29, 2021	52	Motion to Stay (4) Docket Text: MOTION to Stay Pending Instituted Inter Partes Reviews - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy) Modified on 11/30/2021 (nms).
Nov 29, 2021	53	Opening Brief in Support (Main Document) (22) Docket Text: OPENING BRIEF in Support re [52] MOTION to Stay Pending Instituted Inter Partes Reviews, filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..Answering Brief/Response due date per Local Rules is 12/13/2021. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy) Modified on 11/30/2021 (nms).
Nov 29, 2021	53	Opening Brief in Support (Exs. A-E) (30) Docket Text: OPENING BRIEF in Support re [52] MOTION to Stay Pending Instituted Inter Partes Reviews, filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..Answering Brief/Response due date per Local Rules is 12/13/2021. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy) Modified on 11/30/2021 (nms).
Nov 23, 2021	51	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 12/8/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Nov 12, 2021	48	Claim Construction Chart (Main Document) (21) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 1) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 2) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 3) (19) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 4) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 5) (9) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 6) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 7) (6) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 8) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 9) (6) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 10) (19) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 11) (24) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 12) (15) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 13) (23) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	48	Claim Construction Chart (Exhibit 14) (13) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Main Document) (21) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 15) (26) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 16) (7) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 17) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 18) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 19) (28) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 20) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 21) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 22) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 23) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 24) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 25) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 26) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 27) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	49	Claim Construction Chart (Exhibit 28) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Main Document) (21) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 29) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 30) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 31) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 32) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 33) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 34) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 35) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 36) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 37) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 38) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 39) (9) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 40) (7) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 12, 2021	50	Claim Construction Chart (Exhibit 41) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms).
Nov 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to file a joint claim construction chart to November 12, 2021. (43 in 1:20-cv-01734-RGA-JLH, 46 in 1:20-cv-01730-RGA-JLH, 43 in 1:20-cv-01644-RGA-JLH, 77 in 1:20-cv-01646-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Nov 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Parties' proposals regarding the claim construction briefing structure and limitations. (See Letter at 47 in 1:20-cv-01730-RGA-JLH, 79 in 1:20-cv-01646-RGA-JLH, 44 in 1:20-cv-01734-RGA-JLH, 44 in 1:20-cv-01644-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Nov 5, 2021	46	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to file a joint claim construction chart to November 12, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy)
Nov 5, 2021	47	Letter (1) Docket Text: Letter to The Honorable Jennifer L. Hall from Brian E. Farnan regarding Proposal for Claim Construction Briefs. (Farnan, Brian)
Nov 2, 2021	44	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-70) filed by Ravgen, Inc..(Farnan, Brian)
Nov 2, 2021	45	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Requests for the Production of Documents and Things for Plaintiff Ravgen, Inc. (Nos. 1-61) filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Oct 29, 2021	42	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Ravgen's Proposed Claim Constructions filed by Ravgen, Inc..(Farnan, Brian)
Oct 29, 2021	43	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Myriad's Proposed Claim Constructions filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Oct 25, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [39] STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 11/24/2021, [40] STIPULATION TO EXTEND TIME for the parties' deadline to exchange proposed claim constructions to October 29, 2021. ORDERED by Judge Jennifer L. Hall on 10/25/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH. (cna, )
Oct 22, 2021	39	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 11/24/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Oct 22, 2021	40	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties' deadline to exchange proposed claim constructions to October 29, 2021 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee)
Oct 1, 2021	37	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Ravgen's Identification of Claim Terms for Construction filed by Ravgen, Inc..(Farnan, Brian)
Oct 1, 2021	38	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Myriad's Identification of Claim Terms for Construction filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Sep 27, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to submit a Proposed Protective Order to 10/25/2021. (67 in 1:20-cv-01646-RGA-JLH, 34 in 1:20-cv-01644-RGA-JLH, 36 in 1:20-cv-01730-RGA-JLH, 33 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 9/27/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Sep 24, 2021	36	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to 10/25/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Sep 17, 2021	35	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Myriad's Initial Invalidity Contentions filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Aug 31, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time on Certain Scheduling Order Deadlines. (34 in 1:20-cv-01730-RGA-JLH, 65 in 1:20-cv-01646-RGA-JLH, 32 in 1:20-cv-01644-RGA-JLH, 31 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 8/31/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) Modified on 8/31/2021 (ceg).
Aug 30, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time for the submission of the Proposed Protective Order to 9/24/2021. (30 in 1:20-cv-01734-RGA-JLH, 33 in 1:20-cv-01730-RGA-JLH, 64 in 1:20-cv-01646-RGA-JLH, 31 in 1:20-cv-01644-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 8/30/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Aug 27, 2021	34	Stipulation to EXTEND Time (3) Docket Text: STIPULATION to Extend Time on Certain Scheduling Order Deadlines - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified docket text on 8/31/2021 (ceg).
Aug 26, 2021	33	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 9/24/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Jul 30, 2021	32	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Ravgen's Initial Infringement Contentions filed by Ravgen, Inc..(Farnan, Brian)
Jul 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time for the submission of the Proposed Protective Order to 8/27/2021. (31 in 1:20-cv-01730-RGA-JLH, 29 in 1:20-cv-01644-RGA-JLH, 56 in 1:20-cv-01646-RGA-JLH, 28 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 7/29/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Jul 28, 2021	31	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 8/27/2021 - filed by Ravgen, Inc.. (Farnan, Michael)
Jul 20, 2021	30	Notice (Other) (3) Docket Text: NOTICE of Change of Firm Affiliation by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Blumenfeld, Jack)
Jul 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to Submit the Proposed Protective Order to 7/30/2021. (51 in 1:20-cv-01646-RGA-JLH, 27 in 1:20-cv-01644-RGA-JLH, 26 in 1:20-cv-01734-RGA-JLH, 28 in 1:20-cv-01730-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 7/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Jul 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation Amending Scheduling Order. (27 in 1:20-cv-01734-RGA-JLH, 52 in 1:20-cv-01646-RGA-JLH, 29 in 1:20-cv-01730-RGA-JLH, 28 in 1:20-cv-01644-RGA-JLH).. ORDERED by Judge Jennifer L. Hall on 7/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Jul 13, 2021	28	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 7/30/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Jul 13, 2021	29	Stipulation (3) Docket Text: STIPULATION Amending Scheduling Order by Ravgen, Inc.. (Farnan, Brian)
Jun 30, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time to submit a Proposed Protective Order to 7/16/2021. (49 in 1:20-cv-01646-RGA-JLH, 27 in 1:20-cv-01730-RGA-JLH, 26 in 1:20-cv-01644-RGA-JLH, 25 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 6/30/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Jun 30, 2021	27	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to 7/16/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Jun 21, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time for the submission of the proposed Protective Order to 7/2/2021. (25 in 1:20-cv-01644-RGA-JLH, 26 in 1:20-cv-01730-RGA-JLH, 48 in 1:20-cv-01646-RGA-JLH, 24 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 6/21/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Jun 16, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 6/16/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(Taylor, Daniel)
Jun 16, 2021	26	Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 7/2/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Jun 4, 2021	25	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Myriad's Core Technical Document Production Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
Jun 1, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Peter Zhu, Jun Tong, Joze Welsh for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH (myr)
May 25, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, Motion for Pro Hac Vice Appearance of Attorney Peter Zhu, Jun Tong, and Joze Welsh filed by Ravgen, Inc. (24 in 1:20-cv-01730-RGA-JLH, 22 in 1:20-cv-01734-RGA-JLH, 24 in 1:20-cv-01644-RGA-JLH, 45 in 1:20-cv-01646-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 5/25/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
May 25, 2021	24	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter Zhu, Jun Tong, and Joze Welsh - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian)
May 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, [21] Stipulation to Extend Time for defendants Myriad Genetics, Inc. and Myriad Women's Health, Inc. to serve their initial disclosures to May 18, 2021. ORDERED by Judge Jennifer L. Hall on 5/19/2021. (ceg)
May 19, 2021	N/A	Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(Taylor, Daniel)
May 19, 2021	23	Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties and Amendment of Pleadings due by 7/26/2022. Fact Discovery completed by 8/16/2022. Opening Expert Reports due by 10/3/2022. Rebuttal Expert Reports due by 11/17/2022. Expert Discovery due by 2/9/2023. Interim Status Report due by 3/15/2022. Dispositive Motions due by 3/9/2023. Answering Brief due 4/6/2023. Reply Brief due 4/20/2023. A Motion Hearing is set for 5/5/2023 at 01:00 PM before Judge Jennifer L. Hall. Joint Claim Construction Brief due by 3/3/2022. A Markman Hearing is set for 4/12/2022 at 01:00 PM before Judge Jennifer L. Hall. A Trial Ordering and Scheduling Conference is set for 3/2/2023 at 01:00 PM before Judge Jennifer L. Hall. Proposed Final Pretrial Order due by 8/21/2023. A Pretrial Conference is set for 8/25/2023 at 09:00 AM before Judge Richard G. Andrews. A 5 day Jury Trial is set for 9/11/2023 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for complete details). Signed by Judge Jennifer L. Hall on 5/19/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
May 18, 2021	21	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for defendants Myriad Genetics, Inc. and Myriad Women's Health, Inc. to serve their initial disclosures to May 18, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy)
May 18, 2021	22	Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) and (2) Defendants' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy)
May 12, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The cover letter attached to the revised scheduling order has been replaced per the filing party's request. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
May 11, 2021	20	Proposed Order (Main Document) (18) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # (1) Letter)(Farnan, Brian) (Attachment 1 replaced on 5/12/2021) (ceg).
May 11, 2021	20	Proposed Order (Letter to The Honorable Jennifer L. Hall) (1) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # (1) Letter)(Farnan, Brian) (Attachment 1 replaced on 5/12/2021) (ceg).
May 3, 2021	19	Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Michael Ling as co-counsel.. (Farnan, Brian)
Apr 30, 2021	18	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Plaintiff's Initial Disclosures Pursuant to Fed. R. Civ. P. 26; (ii) Ravgen's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI"); and (iii) Ravgen's Preliminary Identification of Asserted Patents and Accused Products filed by Ravgen, Inc..(Farnan, Brian)
Apr 27, 2021	N/A	Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephonic Scheduling Conference held on 4/27/2021. (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Apr 27, 2021	N/A	Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that, as discussed at the scheduling conference, on or before May 11, 2021, the parties shall submit a final version of the scheduling order. ORDERED by Judge Jennifer L. Hall on 4/27/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Apr 23, 2021	N/A	Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER Setting Telephonic Scheduling Conference: A Scheduling Conference is scheduled for April 27, 2021 at 04:00 PM Eastern Time before Judge Jennifer L. Hall. Counsel for Plaintiff shall send dial-in information directly to the Court by 4:00 PM on April 26, 2021 using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. ORDERED by Judge Jennifer L. Hall on 4/23/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg)
Apr 20, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, [15] Motion for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Anne S. Toker and Allyson E. Parks filed by Myriad Women's Health, Inc., Myriad Genetics, Inc. ORDERED by Judge Jennifer L. Hall on 4/20/2021. (ceg)
Apr 20, 2021	15	Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Anne S. Toker and Allyson E. Parks - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. Motions referred to Jennifer L. Hall.(Tigan, Jeremy)
Mar 31, 2021	14	Proposed Order (Main Document) (19) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # (1) Letter)(Farnan, Brian)
Mar 31, 2021	14	Proposed Order (Letter to The Honorable Jennifer L. Hall) (4) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # (1) Letter)(Farnan, Brian)
Mar 26, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, [13] Stipulation to Extend Time to Submit Proposed Scheduling Order and Joint Letter to March 31, 2021. ORDERED by Judge Jennifer L. Hall on 3/26/2021. (ceg)
Mar 26, 2021	13	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order and Joint Letter to March 31, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy)
Mar 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time for the submission of the Proposed Scheduling Order and Joint Letter to 3/29/2021. (C.A. No. 20-cv-1644, D.I. 13; C.A. No. 20-cv-1646, D.I. 22; C.A. No 20-cv-1730, D.I. 12). ORDERED by Judge Jennifer L. Hall on 3/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg)
Mar 15, 2021	12	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Scheduling Order and joint letter to 3/29/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
Feb 12, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent" up through and including paragraph number 17 (i.e., up to and including case dispositive motions) and consistent with paragraphs 13-16 of Judge Andrew's "Rule 16 Scheduling Order - Patent"; and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Orders can be found on Judge Hall's and Judge Andrew's portions of the District Court's website. ORDERED by Judge Jennifer L. Hall on 2/12/2021. (ceg)
Feb 11, 2021	9	Answer to Complaint (12) Docket Text: ANSWER to [1] Complaint, by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Blumenfeld, Jack)
Feb 11, 2021	10	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Myriad Genetics, Inc. for Myriad Women's Health, Inc.; Other Affiliate BlackRock Institutional Trust Company, N.A. for Myriad Genetics, Inc. filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Blumenfeld, Jack)
Jan 13, 2021	N/A	Order Referring Case to Magistrate Judge (0) Docket Text: ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. Associated Cases: 1:20-cv-01644-RGA, 1:20-cv-01646-RGA, 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms)
Jan 7, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, Deborah J. Mariottini for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Jan 5, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (7 in 20-cv-1734-RGA; 8 in 20-cv-1730-RGA) MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini, filed by Ravgen, Inc.. Signed by Judge Richard G. Andrews on 1/5/2021. Associated Cases: 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms)
Jan 5, 2021	8	Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini - filed by Ravgen, Inc.. (Farnan, Brian)
Dec 29, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [6] STIPULATION and Order (*Reset Answer Deadlines: Myriad Genetics, Inc. answer due 2/11/2021; Myriad Women's Health, Inc. answer due 2/11/2021). Signed by Judge Richard G. Andrews on 12/29/2020. (nms)
Dec 29, 2020	6	Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to February 11, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Blumenfeld, Jack)
Dec 29, 2020	7	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ravgen, Inc.. (Farnan, Michael)
Dec 23, 2020	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-01730-RGA, 1:20-cv-01734-RGA (rjb)
Dec 22, 2020	5	Summons Returned Executed (4) Docket Text: SUMMONS Returned Executed by Ravgen, Inc.. Myriad Genetics, Inc. served on 12/22/2020, answer due 1/12/2021; Myriad Women's Health, Inc. served on 12/22/2020, answer due 1/12/2021. (Farnan, Michael)
Dec 21, 2020	1	Complaint* (1)
Dec 21, 2020	1	Complaint (Main Document) (27) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 1) (30) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 2) (30) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 3) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 4) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 5) (26) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 6) (4) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 7) (30) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 8) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 9) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 10) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 11) (5) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 12) (4) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 13) (7) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 14) (4) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 15) (9) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 16) (4) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 17) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 18) (4) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 19) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 20) (8) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 21) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 22) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 23) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 24) (6) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 25) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 26) (8) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 27) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 28) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 29) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 30) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 31) (13) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 32) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 33) (11) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 34) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 35) (2) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	1	Complaint (Exhibit 36) (3) Docket Text: COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33, # (35) Exhibit 34, # (36) Exhibit 35, # (37) Exhibit 36)(sam)
Dec 21, 2020	2	Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
Dec 21, 2020	3	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2 ;US 7,332,277 B2. (sam)
Dec 21, 2020	4	Summons Issued - Electronic (4) Docket Text: Summonses Issued as to Myriad Women's Health, Inc. and Myriad Genetics, Inc. (please complete the top portion of the form and print out for use/service). (sam)

Lawsuits

Ravgen, Inc. v. Myriad Genetics, Inc. et al > Documents